Frequently asked questions
COVID-19 is expected to negatively affect the global Insect Cell Culture market.
North America accounted for the highest share of the global Insect Cell Culture market.
This market is expanding due to rising funding for cell-based research, rising acceptance of single-use technologies, rising need for biopharmaceuticals, rising prevalence of chronic diseases, and rising demand for monoclonal bodies.
The stem cell media segment had a major share in 2021, with more than 40% of the market revenue.
The biopharmaceutical manufacturing segment had a major share in 2021, with more than 30% of the market revenue share.